PHARMAGEST INTER. Share Price Euronext Paris
Stocks
FR0000077687
IT Services & Consulting
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-30 | French and Benelux stocks-Factors to watch | RE |
| 04-29 | Equasens Q1 revenue at 61.4 million euros | RE |
| Market Cap | 571M 661M 526M 493M 923M 62.86B 938M 6.21B 2.42B 30.6B 2.48B 2.43B 106B | P/E Ratio 2025 * |
15.5x | P/E Ratio 2026 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 476M 551M 439M 411M 770M 52.4B 782M 5.18B 2.02B 25.5B 2.07B 2.02B 88.3B | EV / Sales 2025 |
2.86x | EV / Sales 2026 * | 1.81x |
| Free-Float |
31.97% | Yield 2025 * |
3.68% | Yield 2026 * | 4.3% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 21/04/2022 | |
| Director of Finance/CFO | - | 31/12/2022 | |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
CHM | Chairman | 67 | 31/12/2009 |
| Director/Board Member | 61 | 31/12/2008 | |
Daniel Antoine
BRD | Director/Board Member | 74 | 31/12/2001 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | -4.42% | -1.80% | +97.85% | 256B | |
| +1.65% | -4.47% | -45.37% | -45.97% | 105B | |
| +0.96% | -2.47% | -26.27% | +2.59% | 90.42B | |
| +1.21% | -1.71% | -37.27% | -33.37% | 82.27B | |
| -3.17% | -2.30% | +11.82% | +34.21% | 80.68B | |
| +1.22% | -4.74% | -36.02% | -3.34% | 58.94B | |
| +0.16% | -6.77% | -30.31% | -14.44% | 47.53B | |
| -3.18% | -9.22% | -6.00% | +67.91% | 35.3B | |
| -3.02% | -8.79% | -1.75% | +178.66% | 32.12B | |
| Average | -0.57% | -4.98% | -19.22% | +31.57% | 87.52B | |
| Weighted average by Cap. | -0.34% | -4.25% | -17.17% | +35.21% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 236M 273M 217M 204M 381M 25.97B 387M 2.57B 1B 12.64B 1.03B 1B 43.76B | 260M 301M 240M 224M 420M 28.62B 427M 2.83B 1.1B 13.93B 1.13B 1.11B 48.23B |
| Net income | 37.1M 42.95M 34.19M 32M 59.97M 4.08B 60.9M 404M 157M 1.99B 161M 158M 6.88B | 44.5M 51.52M 41.01M 38.38M 71.93M 4.9B 73.05M 484M 189M 2.38B 193M 189M 8.25B |
| Net Debt | -95.08M -110M -87.61M -82.01M -154M -10.46B -156M -1.03B -403M -5.09B -413M -404M -17.63B | -101M -116M -92.7M -86.77M -163M -11.07B -165M -1.09B -427M -5.39B -437M -428M -18.66B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
